| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
1,770,000,000 |
| Market
Cap: |
286.01(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$132.51 - $182.1 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 560 |
| Guru Rank Value : 3 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
459,004 |
461,916 |
540,416 |
1,279,317 |
| Total Sell Value |
$81,195,771 |
$81,646,316 |
$93,320,391 |
$207,372,438 |
| Total People Sold |
9 |
9 |
9 |
14 |
| Total Sell Transactions |
10 |
11 |
13 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Saleki-Gerhardt Azita |
EVP, Operations |
• – – |
2020-11-04 |
4 |
AS |
$93.61 |
$449,328 |
D/D |
(4,800) |
109,067 |
|
11% |
|
| Severino Michael |
Vice Chairman |
• – – |
2020-11-04 |
4 |
S |
$93.61 |
$8,488,461 |
D/D |
(90,679) |
67,281 |
|
-11% |
|
| Rapp Edward J |
Director |
– • – |
2020-09-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,513 |
10,388 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2020-09-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,513 |
25,482 |
|
- |
|
| Alban Carlos |
Vice Chairman |
• – – |
2020-07-07 |
4 |
S |
$100.00 |
$5,332,555 |
D/D |
(53,325) |
114,899 |
|
1% |
|
| Stewart Jeffrey Ryan |
SVP, US Commercial Operations |
• – – |
2020-05-12 |
4 |
S |
$90.00 |
$2,072,211 |
D/D |
(23,024) |
52,760 |
|
-1% |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2020-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
23,196 |
63,538 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
7,882 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
7% |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
7% |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,000 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
114,759 |
|
- |
|
| Austin Roxanne S |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
119,447 |
|
- |
|
| Meyer Melody B |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
9,421 |
|
- |
|
| Waddell Frederick H |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
21,881 |
|
- |
|
| Hart Brett J |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
12,395 |
|
- |
|
| Liddy Edward M |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
25,002 |
|
- |
|
| Freyman Thomas C |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,916 |
119,675 |
|
- |
|
| Roberts Rebecca B |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
6,651 |
|
- |
|
| Durkin Brian L |
VP, Controller |
• – – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
60 |
17,704 |
|
- |
|
| Alpern Robert J |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
28,440 |
|
- |
|
| Rapp Edward J |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
32,995 |
|
- |
|
| Strom Carrie C |
SVP & Pres Global Allerg Aesth |
• – – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
40,342 |
40,342 |
|
- |
|
| Burnside William H.l. |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
19,881 |
|
- |
|
| Tilton Glenn F |
Director |
– • – |
2020-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,333 |
44,487 |
|
- |
|
641 Records found
|
|
Page 12 of 26 |
|
|
0.31 (0.19%) 
